Judy

Judy is a seasoned medical supply chain and equipment lifecycle management expert, currently serving as a core content specialist and procurement advisor at the HHG Secure Medical Equipment Marketplace. She specializes in helping hospitals, private clinics, and research laboratories optimize their hardware assets while navigating the complexities of cross-border procurement, compliance verification, and precision calibration. With a keen eye for industry bottlenecks, Judy has authored extensive analyses on risk mitigation in the medical trade—covering everything from the modular compatibility of minimally invasive surgery tools to software licensing traps in aesthetic devices and strict sterility standards for cardiac equipment. Driven by a "compliance-first" philosophy, she empowers healthcare organizations to eliminate hidden middleman markups and secure reliable, patient-safe hardware within budget.

How Is South Korea’s MFDS Helping Med‑Tech Firms Weather Raw‑Material Shortages?

The MFDS has introduced streamlined guidelines to help medical‑device manufacturers in South Korea respond faster to raw‑material shortages. These measures allow accelerated approvals, simplified documentation, and targeted government support for producers of essential devices and consumables, giving international firms that source from or sell into Korea a clearer route to maintain supply during disruptions. Check: […]

How Is South Korea’s MFDS Helping Med‑Tech Firms Weather Raw‑Material Shortages? Read More »

Knowledge

What Are Best POTS Devices in 2026?

Emerging medical devices like inspiratory resistance devices such as Res-Q-Gard ITD and advanced wearable heart rate monitors help manage Postural Orthostatic Tachycardia Syndrome (POTS). They stabilize heart rate, enhance blood flow, and provide real-time symptom tracking for better daily control and improved quality of life. Check: How Can Healthcare Systems Build a Modern Procurement Strategy

What Are Best POTS Devices in 2026? Read More »

Knowledge

How Can Medical Device Marketing Align with Value-Based Procurement?

Medical device marketing aligns with value-based procurement by focusing on long-term clinical outcomes, cost efficiency, and measurable return on investment. By integrating data-driven messaging, real-world evidence, and stakeholder-specific communication, marketing and sales teams can demonstrate value beyond price, helping healthcare providers make informed, outcome-focused purchasing decisions in an increasingly performance-driven procurement environment. Check: How Can

How Can Medical Device Marketing Align with Value-Based Procurement? Read More »

Knowledge

Choosing a Medical Device Contract Manufacturing Partner in 2026: A Buyer’s Guide

How do you choose the right medical device contract manufacturing partner in 2026? The right partner should align with your device class, regulatory roadmap, and production scale, while offering end‑to‑end services that reduce supply chain fragmentation, shorten time‑to‑market, and strengthen resilience. Prioritizing quality systems, scalability, and long‑term collaboration turns contract manufacturing from a tactical decision

Choosing a Medical Device Contract Manufacturing Partner in 2026: A Buyer’s Guide Read More »

Knowledge

What Are EU MDR & Japan PMDA April 2026 Updates?

In April 2026, EU MDR added new harmonized standards via Implementing Decision (EU) 2026/193 for enhanced device safety, while Japan PMDA extended ICH guidelines to generics, requiring stricter quality dossiers. These shifts extend procurement lead times by 13-18 months due to Notified Body backlogs and documentation demands. Check: How Can Healthcare Systems Build a Modern

What Are EU MDR & Japan PMDA April 2026 Updates? Read More »

Knowledge

How Is the Medical Device Sales Rep Evolving in 2026?

The medical device sales rep is evolving from a brochure‑hand‑off visitor into a data‑driven consultant who uses digital procurement platforms, real‑time analytics, and supply‑chain tools to support hospitals and clinicians. In the digital procurement era, fluency with inventory systems, compliance dashboards, and e‑catalog storefronts is now as critical as clinical knowledge. Global platforms like HHG GROUP are

How Is the Medical Device Sales Rep Evolving in 2026? Read More »

Knowledge

How Is Tech Helping Manage Chronic Venous Insufficiency?

The global market for chronic venous insufficiency medical devices is projected to reach about 1.75 billion USD in 2026, fueled by an aging population, rising obesity, and expanding minimally invasive vascular surgery tech. Smart compression garments, programmable pneumatic pumps, and digital procurement platforms are transforming how care teams prevent ulcers, manage edema, and optimize the

How Is Tech Helping Manage Chronic Venous Insufficiency? Read More »

Knowledge

Why 2026 Is the Year of Usability in Medical Device Design?

In 2026, medical device design is shifting from “feature‑heavy” gadgets to intuitive, user‑centered tools that reduce training time, errors, and hidden hospital costs. Smart interfaces, human‑centered design, and emerging Brain‑Computer Interface (BCI)‑aligned standards are turning usability into a core competitive advantage—and procurement priority—for healthcare providers worldwide. This evolution connects medical device product development directly to

Why 2026 Is the Year of Usability in Medical Device Design? Read More »

Knowledge

Is FDA Understaffing Causing Device Recall Delays?

Yes, FDA understaffing has led to missing 3-month recall termination goals for 74% of 3,934 medical device recalls from 2020-2024, per GAO reports. Hospitals often learn last about unsafe devices, heightening risks—build an internal safety net with UDI tracking via platforms like HHG GROUP. Check: Medical Devices Procurement Strategy 2026: Digital Adoption For Cost-Efficient Care

Is FDA Understaffing Causing Device Recall Delays? Read More »

Knowledge

Is Japan’s 2026 MedTech Surge Unstoppable?

Japan’s 2026 MedTech surge redefines precision healthcare through AI-powered diagnostics and Software as a Medical Device (SaMD), with Fujitsu leading rollouts and PMDA accelerating approvals. This boom tackles aging populations and alarm fatigue via digital-analog innovations, delivering high-ROI Japanese tech to procurement officers. The SaMD market grows to $96M by 2033. Check: Medical Devices Procurement

Is Japan’s 2026 MedTech Surge Unstoppable? Read More »

Knowledge
Shopping Cart